Zymeworks (ZYME) Receivables - Net (2022 - 2026)
Zymeworks (ZYME) reported Receivables - Net of $4.7 million for Q1 2026, down 81.0% on a YoY basis from $24.6 million in Q1 2025, and up 0.78% sequentially from $4.6 million in Q4 2025.
Zymeworks (ZYME) Receivables - Net (2022 - 2026) Analysis & Trends
Zymeworks (ZYME) has 5 years of Receivables - Net data on file, last reported at $4.7 million in Q1 2026.
- For the quarter ending Q1 2026, Receivables - Net fell 81.0% year-over-year to $4.7 million; the trailing twelve-month figure through Mar 2026 stood at $4.7 million (down 81.0% YoY), and the FY2025 full-year result was $4.6 million, down 91.69% from the prior year.
- Receivables - Net improved to $4.7 million in Q1 2026, from $4.6 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $67.3 million in Q3 2023 to a low of $2.6 million in Q2 2025.
- A 5-year average of $30.1 million and a median of $29.4 million in 2025 frame the typical range for Receivables - Net.
- Across the five-year window, Receivables - Net soared 899.9% in 2023 and slumped 91.8% in 2025, its largest moves.
- Tracing ZYME's Receivables - Net over 5 years: stood at $33.4 million in 2022, then sank by 41.69% to $19.5 million in 2023, then surged by 186.57% to $55.8 million in 2024, then sank by 91.69% to $4.6 million in 2025, then increased by 0.78% to $4.7 million in 2026.
- Business Quant data shows ZYME's Receivables - Net at $4.7 million in Q1 2026, $4.6 million in Q4 2025, and $29.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.67 Mn |
| Mar 31, 2026 | 4.67 Mn |
| Dec 31, 2025 | 4.64 Mn |
| Dec 31, 2025 | 4.64 Mn |
| Sep 30, 2025 | 29.35 Mn |
| Sep 30, 2025 | 29.35 Mn |
| Jun 30, 2025 | 2.63 Mn |
| Jun 30, 2025 | 2.63 Mn |
| Mar 31, 2025 | 24.59 Mn |
| Mar 31, 2025 | 24.59 Mn |
| Dec 31, 2024 | 55.82 Mn |
| Dec 31, 2024 | 55.82 Mn |
| Sep 30, 2024 | 23.70 Mn |
| Sep 30, 2024 | 23.70 Mn |
| Jun 30, 2024 | 32.08 Mn |
| Jun 30, 2024 | 32.08 Mn |
| Mar 31, 2024 | 30.95 Mn |
| Mar 31, 2024 | 30.95 Mn |
| Dec 31, 2023 | 19.48 Mn |
| Dec 31, 2023 | 19.48 Mn |